Reversible posterior leukoencephalopathy: a possible threat for psoriatic patients treated with biological agents.
Rebora
A E
AE
Regesta
G
G
D000368:Aged; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D054038:Posterior Leukoencephalopathy Syndrome / Q000150:complications*; D011565:Psoriasis / Q000188:drug therapy*
D007166:Immunosuppressive Agents